Tissue distribution and persistence of arthritogenic and non- arthritogenic Eubacterium cell walls

Clinical and Experimental Rheumatology

Volumn 17, Issue 3, 1999, Pages 281-288

  Simelyte E ^a   Rimpilainen M ^a   Rantakokko, K ^a   Lehtonen, L ^a   Zhang, X ^a   Aho, H ^a   Isomaki P ^a   Toivanen, P ^a  

^a TURKU UNIVERSITY   (Finland)

Author keywords

Eubacterium cell wall; IL 1 ; IL 10; Inbred LEW rats; Muramic acids; Rheumatoid arthritis; TNF

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; MURAMIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; CONTROLLED STUDY; EUBACTERIUM; FEMALE; GAS CHROMATOGRAPHY; IMMUNOHISTOLOGY; MASS SPECTROMETRY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SYNOVIUM; TISSUE DISTRIBUTION;

ANIMALS; ARTHRITIS; CELL WALL; CYTOKINES; EUBACTERIUM; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; IMMUNOHISTOCHEMISTRY; LIVER; LYMPHATIC SYSTEM; RATS; RATS, INBRED LEW; SYNOVIAL MEMBRANE;

EID: 0344759104     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. CROMARTIE WJ, CRADDOCK JC, SCHWAB JH, ANDERLE SK, YANG CH: Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med 1977; 146: 1586-602.
2. WILDER RL, CALANDRA GB, GARVIN AJ, WRIGHT KD, HANSEN CT: Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. Arthritis Rheum 1982; 25: 1064-72.
3. ALLEN JB, MALONE DG, WAHL SM, CALANDRA GB, WILDER RL: Role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation. Comparative studies of pathology and cell wall distribution in athymic and euthymic rats. Clin Invest 1985; 76: 1042-56.
4. YOCUM DE, ALLEN JB, WAHL SM, CALANDRA GB, WILDER RL: Inhibition by cyclosporin A of streptococcal cell wall-induced arthritis and hepatic granulomas in rats. Arthritis Rheum 1986; 29: 262-73.
5. VAN DEN BROEK MF: Streptococcal cell wall-induced polyarthritis in the rat. APMIS 1989; 97: 861-78.
6. VAN DEN BROEK MF, VAN DEN LANGERIJT LG, VAN BRUGGEN MC, BILLINGHAM ME, VAN DEN BERG WB: Treatment of rats with monoclonal anti-CD4 induces long-term resistance to streptococcal cell wall-induced arthritis. Eur J Immunol 1992; 22: 57-61.
7. BRAHN E: Animal models of rheumatoid arthritis. Clin Orthop 1991; 265: 42-53.
8. LEHMAN TJA, ALLEN JB, PLOTZ PH, WILDER RL: Polyarthritis in rats following the systemic injection of Lactobacillus casei cell walls in aqueous suspension. Arthritis Rheum 1983; 26: 1259-65.
9. STIMPSON SA, BROWN RR, ANDERLE SK et al.: Arthropathic properties of cell wall polymers from normal flora bacteria, Infec Immunity 1986; 51: 240-9.
10. SEVERIJNEN AJ, VAN KLEEF R, HAZENBERG MP, VAN DE MERWE JP: Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats. J Rheumatol 1989; 16: 1061-8.
11. SEVERIJNEN AJ, VAN KLEEF R, HAZENBERG MP, VAN DE MERWE JP: Chronic arthritis induced in rats by cell wall fragments of Eubacterium species from the human intestinal flora. Infec Immunity 1990; 58: 523-8.
12. SEVERIJNEN AJ, VAN KLEEF R, GRANDIA AA, VAN DER KWAST TH, HAZENBERG MP: Histology of joint inflammation induced in rats by cell wall fragments of the anaerobic intestinal bacterium Eubacterium aerofaciens. Rheumatol Int 1991; 11: 203-8.
13. SCHWAB JH: Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans. Infec Immunity 1993; 61: 4535-9.
14. JOHANNSEN L: Biological properties of bacterial peptidoglycan. APMIS 1993; 101: 337-44.
15. DZIARSKI R: Binding sites for peptidoglycan on mouse lymphocytes. Cell Immunol 1987; 109: 231-45.
16. DZIARSKI R: Demonstration of peptidoglycan-binding sites on lymphocytes and macrophages by photoaffinity cross-linking. J Biol Chem 1991; 266: 4713-8.
17. DZIARSKI R: Cell-bound albumin is the 70-kDa peptidoglycan-, lipopolysaccharide-, and lipopolyteichoic acid-binding protein on lymphocytes and macrophages. J Biol Chem 1994; 269: 20431-6.
18. GUPTA D, JIN Y, DZIARSKI R: Peptidoglycan induces transcription and secretion of TNF-α and activation of Lyn, extracellular signal-regulated kinase, and Rsk signal transduction proteins in mouse macrophages. J Immunol 1995: 2620-30.
19. MARTIN SA, KARNOVSKY ML, KRUEGER JM, PAPPENHEIMER JR, BIEMANN K: Peptidoglycans as promotors of slow-wave sleep. Structure of the sleep-promoting factor isolated from human urine. J Biol Chem 1984; 259: 12652-8.
20. JOHANNSEN L, TOTH LA, ROSENTHAL RS et al.: Somnogenic, pyrogenic, and hematologic effects of bacterial peptidoglycan. Am J Physiol 1990; 259: R182-6.
21. JOHANNSEN L, WECKE J, OBAL FJ, KRUEGER JM: Macrophages produce somnogenic and pyrogenic muramyl peptides during digestion of staphylococci. Am J Physiol 1991; 260: R126-33.
22. SCHLEIFER KH, KANDLER O: Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 1972; 36: 407-77.
23. SARTOR RB, BOND TM, COMPTON KY, CLELAND DR: Intestinal absorption of bacterial cell wall polymers in rats. Adv Exp Med Biol 1987; 216: 835-9.
24. LICHTMAN SN, KEKU J, SCHWAB JH, SARTOR RB: Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infec Immunity 1991; 59: 555-62.
25. SARTOR RB: Importance of intestinal mucosal immunity and luminal bacterial cell wall polymers in the aetiology of inflammatory joint diseases. Baillières Clin Rheumatol 1989; 3: 223-45.
26. HAZENBERG MP, KLASEN IS, KOOL J, RUSELER-VAN EMBDEN GH, SEVERIJNEN A: Are intestinal bacteria involved in the etiology of rheumatoid arthritis ? APMIS 1992; 100: 1-9.
27. LEHMAN TJA, ALLEN JB, PLOTZ PH, WILDER RL: Bacterial cell wall composition, lysozyme resistance, and the induction of chronic arthritis in rats. Rheumatol Int 1985; 5: 163-7.
28. DALLDORF FG, CROMARTIE WJ, ANDERLE SK, CLARK RL, SCHWAB JH: The relation of experimental arthritis to the distribution of streptococcal cell wall fragments. Amer J Pathol 1980; 100: 383-91.
29. EISENBERG R, FOX A, GREENBLATT JJ, ANDERLE SK, CROMARTIE WJ, SCHWAB JH: Measurement of bacterial cell wall in tissues by solid-phase radioimmunoassay: Correlation of distribution and persistence with experimental arthritis in rats. Infec Immunity 1982; 38: 127-35.
30. LEHMAN TJA, ALLEN JB, PLOTZ PH, WILDER RL: Lactobacillus casei cell wall-induced arthritis in rats: Cell wall fragment distribution and persistence in chronic arthritis-susceptible LEW/N and -resistant F344/ N rats. Arthritis Rheum 1984; 27: 939-42.
31. ANDERLE SK, ALLEN JB, WILDER RL, EISENBERG RA, CROMARTIE WJ, SCHWAB JH: Measurement of streptococcal cell wall in tissues of rats resistant or susceptible to cell wall-induced chronic erosive arthritis. Infec Immunity 1985; 49: 836-7.
32. GILBART J, FOX A: Elimination of group A streptococcal cell walls from mammalian tissues. Infec Immunity 1987; 55: 1526-8.
33. FOX A: Role of bacterial debris in inflammatory diseases of the joint and eye. APMIS 1990; 98: 957-68.
34. AREND WP, DAYER J-M: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 1995; 38: 151-60.
35. FELDMANN M, BRENNAN FM, MAINI RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440.
36. BRENNAN FM: Role of cytokines in experimental arthritis. Clin Exp Immunol 1994; 97: 1-3.
37. VAN DEN BERG WB: Lessons for joint destruction from animal models. Curr Opin Rheumatol 1997; 9: 221-8.
38. STIMPSON SA, DALLDORF FG, OTTERNESS IG, SCHWAB JH: Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J Immunol 1988; 140: 2964-9.
39. WILDER RL, LAFYATIS RT, CASE JP, YOCUM DE, KUMKUMIAN GK, REMMER EF: Cytokines in rheumatoid arthritis and streptococcal cell wall arthritis in the rat. In LEWIS AJ, DOHERTY NS, ACKERMAN NR (Eds.): Therapeutic Approaches to Inflammatory Diseases. New York, Elsevier Science Publishing Co. 1989: 27.
40. SCHWAB JH, ANDERLE SK, BROWN RR, DALLDORF FG, THOMPSON RC: Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infec Immunity 1991; 59: 4436-42.
41. FUSELER JW, CONNER EM, DAVIS JM, WOLF RE, GRISHAM MB: Cytokine and nitric oxide production in the acute phase of bacterial cell-wall induced arthritis. Inflammation 1997; 21: 113-31.
42. SCHIMMER RC, SCHRIER DJ, FLORY CM et al.: Streptococcal cell wall-induced arthritis. Requirements for neutrophils, P-selectin, intercellular adhesion molecule-1, and macrophage-inflammatory protein-2. J Immunol 1997; 159: 4103-8.
43. KATSIKIS PD, CHU C-Q, BRENNAN FM, MAINI RN, FELDMANN M: Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994; 179: 1517-27.
44. ROTT O, FLEISCHER B, CASH E: Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 1994; 24: 1434-40.
45. WALMSLEY M, KATSIKIS PD, ABNEY E et al.: Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 1996; 39: 495-503.
46. PERSSON S, MIKULOWSKA A, NARULA S, O'GARRA A, HOLMDAHL R: Interleukin-10 suppresses the development of collagen type H-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 1996; 44: 607-14.
47. HERFARTH HH, MOHANTY SP, RATH HC, TONKONOGY S, SARTOR RB: Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut 1996; 39: 836-45.
48. FOX A, BROWN RR, ANDERLE SK et al.: Arthropathic properties related to the molecular weight of peptidoglycan-polysaccharide polymers of streptococcal cell walls. Infec Immunity 1982; 35: 1003-10.
49. DISCHE Z, SHETTLES LB: A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. J Biol Chem 1948; 175: 595-603.
50. LEHTONEN L, EEROLA E, OKSMAN P, TOIVANEN P: Muramic acid in peripheral blood leukocytes of healthy human subjects. J Infec Dis 1995; 171: 1060-4.
51. WILDER RL: Streptococcal cell wall-induced polyarthritis in rats. In GREENWALD RA and DIAMOND HS (Eds.): CRC Handbook of Animal Models for the Rheumatic Diseases, vol. 1. Florida, CRC Press, Inc. 1988: 33-40.
52. 125I-labeled peptidoglycan-polysaccharide fragments from group A and group D streptococci. Infec Immunity 1986; 52: 390-6.
53. GILBART J, FOX A, WHITON RS, MORGAN SL: Rhamnose and muramic acid: chemical markers for bacterial cell walls in mammalian tissues. J Microbiol Meth 1986; 5: 271-82.
54. SEN Z, KARNOVSKY ML: Qualitative detection of muramic acid in normal mammalian tissues. Infec Immunity 1984; 43: 937-41.
55. KOOL J, de VISSER H, GERRITS-BOEYE MY et al.: Detection of intestinal flora-derived bacterial antigen complexes in splenic macrophages of rats. J Histochem Cytochem 1994; 42: 1435-41.
56. ROTEN C-AH, KARAMATA D: Endogenous synthesis of peptidoglycan in eukaryotic cells; A novel concept involving its essential role in cell division, tumor formation and the biological clock. Experientia 1992; 48: 921-31.
57. FOX A, SCHWAB JH, COCHRAN T: Muramic acid detection in mammalian tissues by gas-liquid chromatography-mass spectrometry. Infec Immunity 1980; 29: 526-31.
58. WILDER RL, ALLEN JB, WAHL LM, CALANDRA GB, WAHL SM: The pathogenesis of group A streptococcal cell wall-induced polyarthritis in the rat. Arthritis Rheum 1983; 26: 1442-51.
59. STlMPSON SA, LERCH RA, CLELAND DR et al.: Effect of acetylation on arthropathic activity of group A streptococcal peptidoglycan-polysacharide fragments. Infec Immunity 1987; 55: 16-23.
60. JANUSZ MJ, CHETTY C, EISENBERG RA, CROMARTIE WJ, SCHWAB JH: Treatment of experimental erosive arthritis in rats by injection of the muralytic enzyme mutanolysin. J Exp Med 1984; 160: 1360-74.
61. JANUSZ MJ, ESSER RE, SCHWAB JH: In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin. Infec Immunity 1986; 52: 459-67.
62. BENDTZEN K, HANSEN MB, ROSS C, POULSEN LK, SVENSON M: Cytokines and auto-antibodies to cytokines. Stem Cells 1995; 13: 206-22.
63. CUSH JJ, SPLAWSKI JB, THOMAS R et al.: Elevated IL-10 levels in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 96-104.
64. LACKI JK, KLAMA M, MACKIEWICZ SH, MACKIEWlCZ U, MULLER W: Circulating interleukin-10 and interleukin-6 levels in rheumatoid arthritis patients treated with methotrexate or gold salts: Preliminary report. Inflamm Res 1995; 44: 24-6.
65. CICUTTINI FM, BYRON KA, MAKER D, WOOTON AM, MUIRDEN KM, HAMILTON JA: Serum IL-4, IL-10 and IL-6 levels in inflammatory arthritis. Rheumatol Int 1995; 14: 201-6.
66. LAPADULA G, IANNONE F, DELL'ACCIO F, COVELLI M, PIPITONE V: Interleukin-10 in rheumatoid arthritis. Clin Exp Rheumatol 1995; 13: 629-32.
67. MÜLLER K, HERNER EB, STAGG A, BENDTZEN K, WOO P: Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis. Br J Rheumatol 1998; 37: 562-9.